Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Operating Leases: 2021-2025

Historic Operating Leases for Beauty Health (SKIN) over the last 4 years, with Sep 2025 value amounting to $10.6 million.

  • Beauty Health's Operating Leases fell 12.75% to $10.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.6 million, marking a year-over-year decrease of 12.75%. This contributed to the annual value of $10.8 million for FY2024, which is 22.30% down from last year.
  • Beauty Health's Operating Leases amounted to $10.6 million in Q3 2025, which was up 24.57% from $8.5 million recorded in Q2 2025.
  • Beauty Health's 5-year Operating Leases high stood at $17.6 million for Q4 2022, and its period low was $8.5 million during Q2 2025.
  • For the 3-year period, Beauty Health's Operating Leases averaged around $11.4 million, with its median value being $10.8 million (2024).
  • Its Operating Leases has fluctuated over the past 5 years, first increased by 19.67% in 2024, then crashed by 33.33% in 2025.
  • Quarterly analysis of 5 years shows Beauty Health's Operating Leases stood at $16.5 million in 2021, then rose by 7.00% to $17.6 million in 2022, then declined by 21.14% to $13.9 million in 2023, then fell by 22.30% to $10.8 million in 2024, then fell by 12.75% to $10.6 million in 2025.
  • Its last three reported values are $10.6 million in Q3 2025, $8.5 million for Q2 2025, and $9.6 million during Q1 2025.